One of the most commonly mutated genes in lung cancer is the Kirsten rat sarcoma viral oncogene homolog (KRAS), which is mutated in around 30% of all lung adenocarcinomas [11,12]. This evidence concerns the gene KRAS and lung adenocarcinoma.